Accordingly, western blot analysis using p-eIF4E, eIF4E and β-actin antibodies revealed a significant reduced activation of eIF4E in IL-6RαKO and D-KO HCC livers (Supplementary Fig. 4D). This evidence concerns the gene EIF4E and hepatocellular carcinoma.